Country: United Kingdom
Language: English
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Nicotine
Haleon UK Ltd
N07BA01
Nicotine
21mg/24hour
Transdermal patch
Transdermal
No Controlled Drug Status
Valid as a prescribable product
BNF: 04100200; GTIN: 5012131570203 5012131570302
Recto Pharma code XXX Pharma code XXX Patch programme Step 1: Nicotinell TTS 30, 21 mg/24 hour Transdermal Patch Step 2: Nicotinell TTS 20, 14 mg/24 hour Transdermal Patch Step 3: Nicotinell TTS 10, 7 mg/24 hours Transdermal Patch Nicotine Read all of this leaflet carefully because it contains important information for you. This medicine is available without prescription. However, you still need to use Nicotinell Patches carefully to get the best results from them. • Keep this leaflet. You may need to read it again. • Ask your pharmacist if you need more information or advice. • If any of the side effects gets serious, or if you notice any side effect not listed in this leaflet, please tell your doctor or pharmacist. In this leaflet: 1. What Nicotinell Patches are and what they are used for 2. Before you use Nicotinell Patches 3. How to use Nicotinell Patches 4. Possible side effects 5. How to store Nicotinell Patches 6. Further information 1. WHAT NICOTINELL PATCHES ARE AND WHAT THEY ARE USED FOR Nicotinell Patch is a nicotine replacement therapy (NRT) which reduces: • some of the unpleasant withdrawal effects that frequently occur when giving up smoking such as feeling ill or irritable. • your desire to smoke by providing some of the nicotine previously inhaled from cigarettes and therefore helps your willpower to resist cigarettes. If you need advice before starting to use nicotine patches, talk to your doctor, nurse, pharmacist or a trained counsellor. A support programme will increase your chances of quitting smoking. Nicotinell Patches are for application to the skin. When applied to the skin, nicotine passes from the patch, through the skin and into your body. Nicotinell Patches can be used to help you: • stop smoking completely • cut down the amount you smoke – perhaps before you go on to stop completely. In addition, they may be used when you: • do not wish to smoke. For example in confined spaces (in the car: in the house) or where others (such as children) could be harmed by tobacco s Read the complete document
OBJECT 1 NICOTINELL TTS 30 Summary of Product Characteristics Updated 01-May-2018 | GlaxoSmithKline Consumer Healthcare 1. Name of the medicinal product Nicotinell TTS 30 NicAssist 21mg/24 Hour Transdermal Patch 2. Qualitative and quantitative composition Each Nicotinell TTS 30 patch contains 52.5 mg S(-)-nicotine which provides an average absorption rate of 21 mg nicotine in 24 hours. 3. Pharmaceutical form Transdermal patch. The Nicotinell TTS patch is a transdermal therapeutic system, consisting of a round, flat, matrix-type self- adhesive, yellowish-ochre coloured patch. It is protected by a rectangular metallic release liner backing to be discarded before application. Nicotinell TTS 30 patch 21mg/24 Hour has a drug releasing area of 30 cm 2 and is printed CG EME on the patch surface. 4. Clinical particulars 4.1 Therapeutic indications Nicotinell patches relieve and/or prevent cravings and nicotine withdrawal symptoms associated with tobacco dependence. They are indicated to aid smokers wishing to quit or reduce prior to quitting, to assist smokers who are unwilling or unable to smoke, and as a safer alternative to smoking for smokers and those around them. Nicotinell patches are indicated in pregnant and lactating women making a quit attempt. Nicotinell patches should preferably be used in conjunction with a behavioural support programme. 4.2 Posology and method of administration Adults: For individuals smoking 20 cigarettes or more a day, it is recommended that treatment be started with Nicotinell TTS 30 (Step 1) once daily, applied to a dry non-hairy area of the skin on the trunk or upper arm. Those smoking less than this are recommended to start with Nicotinell TTS 20 (Step 2). Sizes of 30cm 2 , 20cm 2 and 10cm 2 are available to permit gradual withdrawal of nicotine replacement, using treatment periods of 3-4 weeks (for each size). The size of patch may be adjusted according to individual response, maintaining or increasing the dose if abstinence is not achieved or if withdrawal symptoms are experienced. Read the complete document